Sexually Transmitted Diseases (STD) Diagnostics Market - Global Industry Analysis

Sexually Transmitted Diseases (STD) Diagnostics Market- By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, and Human Immunodeficiency Virus Testing), By Testing Devices (Laboratory Equipment And Point Of Care Equipment): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2022–2028

Published Date: 15-Mar-2022 Category: Healthcare Report Format : PDF Pages: 184 Report Code: ZMR-558 Status : Published

The global Sexually Transmitted Diseases (STD) Diagnostics Market accrued earnings worth approximately 151 (USD Billion) in 2021 and is predicted to gain revenue of about 256 (USD Billion) by 2028, is set to record a CAGR of nearly 8.3% over the period from 2022 to 2028.

Description

The global Sexually Transmitted Diseases (STD) Diagnostics Market accrued earnings worth approximately 151 (USD Billion) in 2021 and is predicted to gain revenue of about 256 (USD Billion) by 2028, is set to record a CAGR of nearly 8.3% over the period from 2022 to 2028. The study provides assessment and analysis of the Sexually Transmitted Diseases (STD) Diagnostics Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Sexually Transmitted Diseases (STD) Diagnostics Market: COVID-19 Impact Analysis

COVID-19 has become a global challenge for healthcare industry and will have long-lasting effect on sexually transmitted diseases (STD) diagnostics industry. Before pandemic there was rise in sexually transmitted diseases as there were no restrictions on movement of people and the latter could visit sex workers. However, lockdowns and restrictions on movement of people during COVID-19 times resulted in zero or negligible visits (frequency) of people to sex workers, thereby resulting in reduction in sexually transmitted disease infection among people. This has caused disruption in growth of sexually transmitted diseases (STD) diagnostics market. Apart from this, a large number of non-emergency visits were delayed during COVID pandemic and were converted into online tools for preventing doctors & patients from getting infected from COVID virus.

Global Sexually Transmitted Diseases (STD) Diagnostics Market

Sexually Transmitted Diseases (STD) Diagnostics Market: Outlook

Early diagnosing of sexually transmitted diseases is predicted to minimize effect of disease on human health. Reportedly, if sexually transmitted diseases such as syphilis, gonorrhea, human papillomavirus, chlamydia, and genital herpes are not treated in time, it can result in long-term complications in affected persons. These complications encompass mental retardation, blindness, infertility, birth defects, cancer, heart disorders, and bone deformities in patients. Moreover, healthcare service providers diagnose sexually transmitted diseases through physically examination of subjects, blood tests, and through use of swabbed cultures at labs. Sexual transmitted diseases (STD) diagnosis involves lab testing and screening. Lab tests can recognize cause and identify co-infection through testing of blood, urine, and fluid samples. For the record, sexually transmitted disease patients are treated by prescribing them medications such as antiviral drugs and antibiotics.  

Furthermore, researchers at NIAID had carried out immunological studies for knowing as to why large number of sexually transmitted ailments in individuals is asymptomatic. Moreover, these studies have unleashed that how mutation in the infection accounted notably towards drug resistance in STD patients due to constant infection & co-infection. This can pose a big challenge to growth of sexually transmitted diseases (STD) diagnostics market.

Sexually Transmitted Diseases (STD) Diagnostics Market: Growth Factors

  • Growth Drivers: Rise in awareness about educational campaigns and supportive government schemes will proliferate size of sexually transmitted diseases (STD) diagnostics market over ensuing years. Furthermore, increase in persons having living relationships with many partners and people having sexual encounters with more than one partner resulting in causing of sexually transmitted diseases will boost market trends.
  • Restraints: Growing importance of sex education and reduction in taboo related to discussion over topics such as sexual activities & sexual arousal will hinder market surge. Rise in awareness about spread of sexually transmitted diseases such as HIV and need of avoiding it by taking preventive measures such as use of condoms can decrement growth of sexually transmitted diseases (STD) diagnostics market.
  • Opportunities: Rise in point of care testing activities due to influx of new diagnostic kits, reagents, and instruments will create new growth avenues for sexually transmitted diseases (STD) diagnostics market. Reportedly, technologically advanced equipment in diagnostics domain offers precise testing outcomes, thereby driving market size.
  • Challenges: Fluctuating costs of raw materials impacting demand and supply of diagnostics devices has severely impacted import & export of raw materials as well as production of sexually transmitted diseases devices, thereby posing a huge challenge to expansion of sexually transmitted diseases (STD) diagnostics market.

Sexually Transmitted Diseases (STD) Diagnostics Market: Segmentation

Based on segmentation, sexually transmitted diseases (STD) diagnostics market is segregated into type and testing devices. Based on type, the market is divided into chlamydia testing, gonorrhea testing, human papilloma virus testing, syphilis testing, herpes simplex virus testing, and human immunodeficiency virus testing. In terms of testing devices, the industry is sectored into laboratory equipment and point of care equipment.

Chlamydia Testing To Dominate Type Segment Over 2022-2028

Growth of chlamydia testing segment over forecasting timeframe can be attributed to low barrier protection and less awareness about chlamydia disease in under-developed and third world countries.

Laboratory Equipment Segment To Contribute Humungously Towards Market Size By 2028

Massive demand for laboratory devices for testing & diagnosing sexually transmitted diseases in individuals will boost segmental growth. Furthermore, most of diagnostic testing takes place in labs, thereby generating huge need of lab equipment.  

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Sexually Transmitted Diseases (STD) Diagnostics Market: Regional Landscape

Asia Pacific Sexually Transmitted Diseases (STD) Diagnostics Market To Witness Sizable Surge In 2022-2028

Expansion of regional market over assessment period is due to lesser use of contraceptives by both men and women in underdeveloped as well as developing economies & rural areas of sub-continent. Apart from this, favorable regional government schemes for bringing improvement in sexual health of individuals will drive regional market growth.

Key Industry Participants

Mammoth players have strongly impacted expansion of sexually transmitted diseases (STD) diagnostics industry and are likely to maintain strong market position even in foreseeable future. They are Cepheid Inc., Roche Holdings AG, Affymetrix, Abbott Laboratories, Becton Dickinson and Company, DiaSorin, Hologic Inc., Danaher Corporation, bioMerieux SA, and Orasure Technologies.

Breakthroughs in Sexually Transmitted Diseases (STD) Diagnostics Market

  • In April 2019, Quest Diagnostics introduced three laboratory testing packages for diagnosing sexually transmitted diseases in the U.S. Reportedly, these packages can be purchased online for diagnosing frequently occurring sexually transmitted diseases across the U.S.
  • In February 2022, Lupin Limited – Mumbai-based Indian Pharmaceutical firm- received approval from U.S. FDA for use of its antibiotic Solosec for treating sexually transmitted infection referred as trichomoniasis and vaginal infection termed as bacterial vaginosis in women.
  • In February 2022, Trinity Biotech – a Medical Laboratory Company based in Ireland & specializing in production and marketing of clinically diagnostic products- has got approval of WHO for HIV screening test.

The global Sexually Transmitted Diseases (STD) Diagnostics Market is segmented as follows:

By Type

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing

By Testing Devices

  • Laboratory Equipment
  • Point of Care Equipment

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. STD Diagnostics Market, 2016-2026 (USD Billion)
    • 2.2. STD Diagnostics Market: Snapshot
  • Chapter 3. STD Diagnostics Market - Industry Analysis
    • 3.1. STD Diagnostics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rapid Spread Of Human Papilloma Virus (HPV) Infection
    • 3.3. Restraints
      • 3.3.1. Lack Of Education Regarding The Prevalence Of STD Problem
    • 3.4. Opportunity
      • 3.4.1. Covering Untapped Market
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Type
      • 3.6.2. Market attractiveness analysis By Testing Device
      • 3.6.3. Market attractiveness analysis By End-User
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. STD Diagnostics Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global STD Diagnostics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Type launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global STD Diagnostics Market -Type Analysis
    • 5.1. Global STD Diagnostics Market overview: By Type type
      • 5.1.1. Global STD Diagnostics Market share, By Type,2019 and 2026
    • 5.2. Chlamydia Testing
      • 5.2.1. Global STD Diagnostics Market by Chlamydia Testing, 2016-2026 (USD Billion)
    • 5.3. Syphilis Testing
      • 5.3.1. Global STD Diagnostics Market by Syphilis Testing, 2016-2026 (USD Billion)
    • 5.4. Gonorrhea Testing
      • 5.4.1. Global STD Diagnostics Market by Gonorrhea Testing, 2016-2026 (USD Billion)
    • 5.5. Herpes Simplex Virus Testing
      • 5.5.1. Global STD Diagnostics Market by Herpes Simplex Virus Testing, 2016-2026 (USD Billion)
    • 5.6. Human Papilloma Virus Testing
      • 5.6.1. Global STD Diagnostics Market by Human Papilloma Virus Testing, 2016-2026 (USD Billion)
    • 5.7. Human Immunodeficiency Virus Testing
      • 5.7.1. Global STD Diagnostics Market by Human Immunodeficiency Virus Testing, 2016-2026 (USD Billion)
    • 5.8. Others
      • 5.8.1. Global STD Diagnostics Market by others, 2016-2026 (USD Billion)
  • Chapter 6. Global STD Diagnostics Market -Testing Device Analysis
    • 6.1. Global STD Diagnostics Market overview: By Testing Device
      • 6.1.1. Global STD Diagnostics Market share, By Testing Device, 2019 and 2026
    • 6.2. Laboratory Devices
      • 6.2.1. Global STD Diagnostics Market By Laboratory Devices, 2016-2026 (USD Billion)
    • 6.3. Point Of Care Device
      • 6.3.1. Global STD Diagnostics Market By Point Of Care Device, 2016-2026 (USD Billion)
  • Chapter 7. Global STD Diagnostics Market -End-User Analysis
    • 7.1. Global STD Diagnostics Market overview: By End-User
      • 7.1.1. Global STD Diagnostics Market share, By End-User, 2019 and 2026
    • 7.2. Hospitals
      • 7.2.1. Global STD Diagnostics Market by Hospitals, 2016-2026 (USD Billion)
    • 7.3. Others
      • 7.3.1. Global STD Diagnostics Market by others, 2016-2026 (USD Billion)
  • Chapter 8. Global STD Diagnostics Market - Regional Analysis
    • 8.1. Global STD Diagnostics Market overview: by Region
      • 8.1.1. Global STD Diagnostics Marketshare, by Region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.2.2. North America STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.2.3. North America STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.2.4. North America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.2.5.2. The U.S.STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.2.5.3. The U.S.STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.2.6.2. Rest of North America STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.2.6.3. Rest of North America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.3.2. Europe STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.3.3. Europe STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.3.4. Europe STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. U.K.STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.5.2. U.K.STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.5.3. U.K. STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.6.2. France STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.6.3. France STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.7. Germany
        • 8.3.7.1. Germany STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.7.2. Germany STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.7.3. Germany STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeSTD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.3.8.2. Rest of EuropeSTD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.3.8.3. Rest of Europe STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.4.2. Asia Pacific STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.4.3. Asia Pacific STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.4.4. Asia Pacific STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.5.2. China STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.5.3. China STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.6.2. Japan STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.6.3. Japan STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.7.2. India STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.7.3. India STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.5.2. Latin America STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.5.3. Latin America STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.5.4. Latin America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.5.5.2. Brazil STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.5.5.3. Brazil STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
        • 8.5.6.2. Rest of LatinAmerica STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
        • 8.5.6.3. Rest of Latin America STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa STD Diagnostics Market, 2016-2026 (USD Billion)
      • 8.6.2. The Middle East and Africa STD Diagnostics Market revenue, By Type,2016-2026 (USD Billion)
      • 8.6.3. The Middle East and Africa STD Diagnostics Market revenue, By Testing Device, 2016-2026 (USD Billion)
      • 8.6.4. The Middle East and Africa STD Diagnostics Market revenue, By End-User, 2016-2026 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Roche Holdings AG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Type Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Abbott Laboratories
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Type Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Becton Dickinson and Company
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Type Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Hologic Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Type Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Danaher Corporation
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Type Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Affymetrix
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Type Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. bioMerieux
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Type Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Cepheid Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Type Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Alere Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Type Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. DiaSorin
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Type Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development
    • 9.11. Orasure
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Type Portfolio
      • 9.11.4. Business Strategy
      • 9.11.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global STD Diagnostics Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global STD Diagnostics Market attractiveness, By Type 
6. Global STD Diagnostics Market attractiveness, By Testing Device
7. Global STD Diagnostics Market attractiveness, By End-User
8. Global STD Diagnostics Marketmarket share, By Type, 2019 and 2026
9. Global STD Diagnostics Market by Chlamydia Testing, 2016–2026 (USD Billion)
10. Global STD Diagnostics Market by Syphilis Testing,2016–2026 (USD Billion)
11. Global STD Diagnostics Market by Gonorrhea Testing,2016–2026 (USD Billion)
12. Global STD Diagnostics Market by Herpes Simplex Virus Testing,2016–2026 (USD Billion)
13. Global STD Diagnostics Market by Human Papilloma Virus Testing,2016–2026 (USD Billion)
14. Global STD Diagnostics Market by Human Immunodeficiency Virus Testing,2016–2026 (USD Billion)
15. Global STD Diagnostics Market by others,2016–2026 (USD Billion)
16. Global STD Diagnostics Market share, By Testing Device, 2019 and 2026
17. Global STD Diagnostics Market By Laboratory Devices, 2016–2026 (USD Billion)
18. Global STD Diagnostics Market By  Point Of Care Device, 2016–2026 (USD Billion)
19. Global STD Diagnostics Market share, By End-User, 2019 and 2026
20. Global STD Diagnostics Market by Hospitals, 2016–2026 (USD Billion)
21. Global STD Diagnostics Market by others, 2016–2026 (USD Billion)
22. Global STD Diagnostics Market share, by Region, 2019and 2026
23. North America STD Diagnostics Market, 2016–2026 (USD Billion)
24. Europe STD Diagnostics Market, 2016–2026 (USD Billion)
25. Asia Pacific STD Diagnostics Market, 2016–2026 (USD Billion)
26. Latin America STD Diagnostics Market, 2016–2026 (USD Billion)
27. The Middle East and Africa STD Diagnostics Market, 2016–2026 (USD Billion)


Table Of Tables

List of Tables

1. Global STD Diagnostics Market: snapshot
2. Drivers of theSTD Diagnostics Market: impact analysis
3. Restraints of theSTD Diagnostics Market: impact analysis
4. North America STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
5. North America STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
6. North America STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
7. The U.S. STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
8. The U.S. STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
9. The U.S. STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
10. Rest of North America STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
11. Rest of North America STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
12. Rest of North America STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
13. Europe STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
14. Europe STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
15. Europe STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
16. U.K.STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
17. U.K.STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
18. U.K. STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
19. France STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
20. France STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
21. France STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
22. Germany STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
23. Germany STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
24. Germany STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
25. Rest of EuropeSTD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
26. Rest of EuropeSTD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
27. Rest of Europe STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
28. Asia Pacific STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
29. Asia Pacific STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
30. Asia Pacific STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
31. China STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
32. China STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
33. China STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
34. Japan STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
35. Japan STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
36. Japan STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
37. India STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
38. India STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
39. India STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
40. Rest of Asia Pacific STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
41. Rest of Asia Pacific STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
42. Rest of Asia Pacific STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
43. Latin America STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
44. Latin America STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
45. Latin America STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
46. Brazil STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
47. Brazil STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
48. Brazil STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
49. Rest of Latin America STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
50. Rest of Latin America STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
51. Rest of Latin America STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)
52. The Middle East and Africa STD Diagnostics Market revenue, By Type,2016–2026 (USD Billion)
53. The Middle East and Africa STD Diagnostics Market revenue, By Testing Device, 2016–2026 (USD Billion)
54. The Middle East and Africa STD Diagnostics Market revenue, By End-User, 2016–2026 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global STD Diagnostics market. Zion Research has collected and analyzed key data belong to the global STD Diagnostics market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of STD Diagnostics across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the STD Diagnostics industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the STD Diagnostics market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The term sexually transmitted diseases or STD are commonly used to refer to clinical syndromes and infectious diseases caused by pathogens that can be acquired and transmitted through sexual activity. These infections can easily spread by vaginal or anal intercourse, and sometimes by oral sex. STDs can also spread from the blood of infected patients. In addition, pregnant women with STD’s may pass their infection to infants in the uterus (womb), during birth, or through breast-feeding. Prevention of STD infection is possible by having protective sex (using condoms) or abstaining from the sex.

Globally, STD diagnostics market has been accelerated by the rise in the percentage of unprotected sex which leads to increase in the prevalence of sexually transmitted diseases. Furthermore, lack of awareness coupled with unprotected sex is considered as major governing factors which promote the cause of sexually transmitted diseases and thus STD diagnostic market. Moreover, many lifestyle-related factors, such as having multiple sex partners are estimated to drive the sexual transmitted diseases diagnostic market. However, lack of education, psychological impact and the unwillingness of the infected population to undergo prognosis is expected to hinder the growth of the market. In addition, prevention of infection by vaccination is major restraining factor in a growth of STDs diagnostic market.

Based on the type, the global market of STD diagnostic test is bifurcated into seven types: chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papiloma virus testing, human immunodeficiency virus testing and others. Global HIV diagnostics market size was approximately USD 2.77 billion in 2019, with a CAGR of 9.5% during the forecast period. The PAP smear tests segment accounted for the largest share of approximately more than 50% of the total HPV testing market in 2019. Factors attributed to its growth due to its lower test prices and growing awareness about the cancer diagnosis. Similarly, the HPV testing market is forecast to grow at the fastest growth rate within the forecast period.

Based on end-user, the global market for STD diagnostic test is bifurcated into two types: hospital and others. In end-user segment, the hospital was the leading segment in 2019 and this segment will remain in continuous growth during the forecast period due to the continuous rise in HPV virus across the globe.

Based on the testing device, the global market for STD diagnostic test is segmented into two major types: laboratory testing device and point of care device. The laboratory testing device market is further sub-segmented into thermal cyclers - PCR, lateral flow readers – immunochromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA) and others

Based on geographies, the global market for STD diagnostic is bifurcated into five types: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global STD diagnostic market followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, STD diagnostics market has the huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of sexually transmitted diseases, increasing government support, and growing upper middle-class population and rise in disposable income levels in this region.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Surge in awareness about educational campaigns and favorable government policies will steer growth of Sexually Transmitted Diseases (STD) Diagnostics Market over next six years.   

According to Zion market research report, The global Sexually Transmitted Diseases (STD) Diagnostics Market accrued earnings worth approximately 151 (USD Billion) in 2021 and is predicted to gain revenue of about 256 (USD Billion) by 2028, is set to record a CAGR of nearly 8.3% over the period from 2022 to 2028.

Asia Pacific will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is due to lesser use of contraceptives by both men and women in underdeveloped as well as developing economies & rural areas of sub-continent.  

The key market participants leveraging business sphere include Cepheid Inc., Roche Holdings AG, Affymetrix, Abbott Laboratories, Becton Dickinson and Company, DiaSorin, Hologic Inc., Danaher Corporation, bioMerieux SA, and Orasure Technologies.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed